Description
Rôles et compétences
Rôles et compétences
- Reflections and experiences of early career cancer nurses on cancer survivorship in Europe: A qualitative study.on 16 février 2026
European Journal of Oncology Nursing; 02/01/2026This study explores how early-career cancer nurses across Europe conceptualise and deliver survivorship care, a growing priority in oncology nursing. […]
Formation et apprentissage
- Symptom Management Guideline Implementation Among Nurses in Cancer-Specific Outpatient Settings: A Scoping Review of Barriers, Facilitators, and Implementation Strategies.on 10 Décembre 2025
Cancer Nursing; 01/01/2026Background: Oncology outpatients experience high levels of distressing cancer-related symptoms. Nurses can provide high-quality outpatient cancer symptom management […]
Spécialités cliniques
Oncologie médicale
- Association between gut microbiota composition signature and the risk of chemotherapy-induced complications in tumor patients: a systematic review and meta-analysis...Eighth Pan-Pacific Nursing Conference cum Second Cochrane Hong Kong Symposium, March 24–28, 2026, Hong Kong SAR, China.on 21 mai 2026
International Journal of Nursing Studies; 06/02/2026(AN 193498928); ISSN: 00207489CINAHL Complete
Chirurgie oncologique
- The AMICO Clinic Approach to Integrative Oncology in Breast Cancer Care: Structure and Clinical Framework From a Southern Italian Hospitalon 16 mars 2026
Integr Cancer Ther. 2026 Jan-Dec;25:15347354251413227. doi: 10.1177/15347354251413227. Epub 2026 Feb 16.ABSTRACTWith increasing survival rates for breast cancer (BC)-91% at 5 years and 80% at 15 […]
Radio-oncologie
- Alternative splicing in cancer drug resistance: Mechanisms and therapeutic prospects (Review)on 5 Décembre 2025
Oncol Rep. 2026 Feb;55(2):31. doi: 10.3892/or.2025.9036. Epub 2025 Dec 5.ABSTRACTAlternative splicing (AS) is one of the principal mechanisms of post‑transcriptional regulation that confers […]
Traitements et interventions
Traitements non-pharmacologiques
- The Influence of Music on Perceived Pain and Levels of Anxiety While Undergoing Transperineal Prostate Biopsy: The VIVALDI Trialon 21 mai 2026
Eur Urol Open Sci. 2026 Apr 16;87:107-114. doi: 10.1016/j.euros.2026.03.017. eCollection 2026 May.ABSTRACTBACKGROUND: Music has been shown to reduce pain and anxiety during invasive procedures such […]
Approches complémentaires
- Effectiveness of and implementation requirements for telehealth in palliative care patients with advanced cancer: A systematic review and meta-analysis.on 21 mai 2026
Palliative Medicine; 05/01/2026Background: Telehealth is being integrated with palliative care for patients with advanced cancer to improve access to specialized palliative care. However, its […]
Réadaptation, physiothérapie et ergothérapie
- Efficacy of Cognitive Training for Treating Cancer-related Cognitive Impairment: Systematic Review and Meta-analysis by Cognitive Domainon 21 mai 2026
Neuropsychol Rev. 2026 May 4. doi: 10.1007/s11065-026-09699-5. Online ahead of print.ABSTRACTCognitive Training (CT) is proposed to improve cancer-related cognitive impairment (CRCI), but its effect […]
Éducation aux patients et littératie en santé
- Large Language Models for Patient Education: Insights from Cross-Lingual Expert Evaluation in Radioligand Therapy for Neuroendocrine Tumorson 21 mai 2026
J Cancer Educ. 2026 Apr 28. doi: 10.1007/s13187-026-02886-1. Online ahead of print.NO ABSTRACTPMID:42047982 | DOI:10.1007/s13187-026-02886-1
Organisation des soins
Organisation et unités de soins
- Interventional Oncology Is an Evolving Subspecialty for Oncology Nurses.on 16 février 2026
ONS Voice; 02/03/2026Although usually offered in larger, comprehensive cancer centers, IO is expanding as new discoveries and applications emerge. Many oncology nurses could come in contact with […]
Trajectoires de soins
- Return to work for health professionals with breast cancer as health recipients: A systematized reviewon 16 mars 2026
Work. 2026 Feb 16:10519815251410109. doi: 10.1177/10519815251410109. Online ahead of print.ABSTRACTBackgroundHealth professionals are at increased breast cancer(BC) risk. Occupational factors are […]
Performance et indicateurs
- Educational intervention in advanced practice nursing for managing symptoms, toxicities, and quality of life in patients with lung canceron 16 février 2026
Enferm Clin (Engl Ed). 2026 Feb 12:502402. doi: 10.1016/j.enfcle.2026.502402. Online ahead of print.ABSTRACTOBJECTIVE: To evaluate the effectiveness of a proactive educational telephone intervention, […]
Amélioration de la qualité et meilleures pratiques
- Patient Advocate-Trainee Engagement in Oncology Education: Insights from a Short Pilot Surveyon 16 janvier 2026
J Cancer Educ. 2026 Jan 16. doi: 10.1007/s13187-025-02823-8. Online ahead of print.NO ABSTRACTPMID:41543684 | DOI:10.1007/s13187-025-02823-8
Innovation
- Evaluation of symptom-management medications for predicting short-term survival in advanced cancer patients with machine learningon 16 février 2026
Digit Health. 2026 Feb 3;12:20552076261419945. doi: 10.1177/20552076261419945. eCollection 2026 Jan-Dec.ABSTRACTOBJECTIVE: Estimating the diverse symptoms of patients with advanced cancer is helpful […]
Expériences des patients
Expériences des patients
- Systematic Review and Meta-Analysis of Patient Experiences of Oesophageal Cancer Survivorship After Oesophagectomyon 21 mai 2026
Psychooncology. 2026 May;35(5):e70482. doi: 10.1002/pon.70482.ABSTRACTBACKGROUND: Despite improving survival rates, the complexity of post-operative survivorship for oesophageal cancer patients […]
Participation des patients
- Support through experience: The contribution of patient partners in oncologyon 16 janvier 2026
Soins. 2026 Jan-Feb;71(902):61-64. doi: 10.1016/j.soin.2025.11.015. Epub 2025 Dec 19.ABSTRACTThis article presents qualitative research, conducted in partnership with patient-partners-researchers, […]
Résultats rapportés par les patients
- Chest Wall Perforator Flaps in Breast Cancer Surgery: A Systematic Review of Clinical Outcomes, Complications, and Patient-Reported Satisfactionon 21 mai 2026
World J Surg. 2026 May 7. doi: 10.1002/wjs.70393. Online ahead of print.ABSTRACTBACKGROUND: Chest wall perforator flaps (CWPFs) offer a promising, volume-preserving reconstructive option for patients […]
Survivance
- Sexual dysfunction among melanoma survivors: a scoping review of current evidence and clinical gapson 21 mai 2026
BMC Cancer. 2026 May 18. doi: 10.1186/s12885-026-16177-x. Online ahead of print.ABSTRACTSexual health is a fundamental component of quality of life that is frequently compromised in cancer patients. […]
Publications d'associations professionnelles
Canadian Association of Nurses in Oncology (CANO/ACIO)
- Therapeutic breakthroughs in oncology: Enhancing treatment and managementon 11 septembre 2025
Can Oncol Nurs J. 2025 Jul 1;35(4):590-605. doi: 10.5737/23688076354590. eCollection 2025.ABSTRACTRecent advancements in oncology have significantly transformed cancer treatment and care management, offering new hope to patients worldwide. This literature review examines key therapeutic breakthroughs, including targeted therapies, immunotherapies, personalized medicine, and innovative drug delivery systems. These cutting-edge interventions have enhanced patient outcomes, improving survival rates and quality of life, but they have also introduced complexities in managing emerging side effects, care coordination, and resource allocation. This review discusses the implications of these therapies on patient care, the ethical considerations they entail, the management of side effects, and the pivotal role of oncology nurses in administering and managing these treatments. By exploring the current landscape and future directions of oncology therapies, including areas such as cancer vaccines and precision medicine, this article provides a comprehensive understanding of how these innovations are shaping the future of cancer care.PMID:40873601 | PMC:PMC12379890 | DOI:10.5737/23688076354590
Oncology Nursing Society (ONS)
- ONS OCN® Certification Review Bundle Part 2: Oncology Nursing Practice Across the Cancer Continuum™on 13 avril 2026
ONS OCN® Certification Review Bundle Part 2: Oncology Nursing Practice Across the Cancer Continuum™ Kristina M. Gantner March 31, 2026 Products in Bundle ONS Scientific Basis of Cancer™ ONS Site-Specific Cancer Considerations™ ONS Psychosocial Dimensions of Cancer Care™ ONS Care Continuum™ ONS Oncology Professional Practice™ Teaser text The ONS OCN® Certification Review Bundle Part 2: Oncology Nursing Practice Across the Cancer Continuum™ provides essential, evidence‑based education aligned with the Oncology Nursing Certification Corporation (ONCC®) OCN® Test Content Outline to support certification preparation and strengthen real‑world oncology nursing practice. Member Price $290.00 Non-Member Price $240.00
American Society of Clinical Oncology (ASCO)
- Cascade Genetic Testing Among Relatives at Risk for Lynch Syndrome: A Systematic Review and Meta-Analysison 20 mai 2026
JCO Oncol Pract. 2026 Apr 29:OP2600004. doi: 10.1200/OP-26-00004. Online ahead of print.ABSTRACTPURPOSE: This is a systematic review and meta-analysis to evaluate the uptake of cascade genetic counseling and testing within families with Lynch syndrome. Our goal was to provide a more current estimate of testing rates specific to this population to inform future efforts aimed at improving the identification of individuals with Lynch syndrome.METHODS: This systematic review is reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and was preregistered with PROSPERO (registration No.: CRD42024542006). A comprehensive literature search was conducted on electronic databases. Data from eligible studies were meta-analyzed to determine uptake rates of cascade genetic counseling and testing within families with Lynch syndrome.RESULTS: Across all 18 studies included in the meta-analysis, there was a total of 4,939 probands, and 10,461 relatives were used in the evaluation of the uptake rate of cascade genetic testing. Eight of these studies reported on the uptake of genetic counseling for cascade testing, with 42% (95% CI, 18 to 67) of relatives engaging in counseling. Across the 18 studies in the meta-analysis, the overall uptake of cascade genetic testing was 46% (95% CI, 32 to 60), with higher uptake among female compared with male relatives, and among first-degree compared with second-degree relatives.CONCLUSION: The utilization of cascade genetic testing among people at risk for Lynch syndrome remains suboptimal, particularly among male relatives and more distant relatives. Targeted interventions are urgently needed to improve equitable uptake rates of cascade genetic testing among relatives at risk for Lynch syndrome.PMID:42054623 | DOI:10.1200/OP-26-00004
National Comprehensive Cancer Network (NCCN)
- NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026on 20 mai 2026
J Natl Compr Canc Netw. 2026 May;24(5):140-149. doi: 10.6004/jnccn.2026.0023.ABSTRACTThe NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions on select 2026 updates to the guidelines regarding nonmetastatic disease: the elimination of the very-low-risk group, updates to the Principles of Active Surveillance, and caution in the use of focal therapy in newly diagnosed patients.PMID:42134408 | DOI:10.6004/jnccn.2026.0023
European Society for Medical Oncology (ESMO)
- EMA Recommends Extension of Indications for Nivolumabon 20 mai 2026
New indication concerns a combination with AVD chemotherapy regimen for the treatment of adults and adolescents with previously untreated Stage III or IV cHL
Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.
Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.
Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.
|
Avis de non-responsabilité
Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit. Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.
Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées. Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.
Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42). Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité. Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables. |


